Gregory Fraser

Stock Analyst at Truist Securities

(1.98)
# 1002
Out of 5,330 analysts
40
Total ratings
50.00%
Success rate
29.92%
Average return
13 Stocks
Name Action PT Current % Upside Ratings Updated
ANIP ANI Pharmaceuticals
Maintains: Hold
62 65
72.86 -10.79% 9 Apr 21, 2025
JAZZ Jazz Pharmaceuticals
Maintains: Strong Buy
220 230
120.03 91.62% 1 Mar 6, 2025
BHC Bausch Health Compan...
Maintains: Hold
8 7
5.42 29.15% 2 Jul 25, 2024
XAIR Beyond Air
Maintains: Buy
10 8
0.2 3900% 6 Apr 30, 2024
BTMD Biote
Maintains: Buy
10 9
3.47 159.37% 2 Jan 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 7
7.98 -12.28% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 29
72.86 -60.2% 5 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95
18.18 422.55% 3 Jun 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
14 18
12.09 48.88% 2 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 40
15.23 162.64% 2 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Aug 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 3
n/a n/a 2 May 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 6
n/a n/a 1 Apr 14, 2022